NCT04059107

Brief Summary

This is a study being performed to evaluate the safety and effectiveness of 3D printed myoelectric prosthetic devices in children with a congenital upper limb deficiency.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2019

Completed
1 day until next milestone

Study Start

First participant enrolled

July 3, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 16, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

March 10, 2021

Status Verified

March 1, 2021

Enrollment Period

2.2 years

First QC Date

July 2, 2019

Last Update Submit

March 9, 2021

Conditions

Outcome Measures

Primary Outcomes (5)

  • Primary Safety Endpoint - Measuring safety of the device through adverse event reporting.

    The safety of the device will be measured through parental reporting and recorded observations of adverse events.

    12 months

  • Children's experiences of using the myoelectric device while performing bi-manual tasks as assessed using a self-report questionnaire.

    This assessment will measure the ability of the user to perform day-to-day tasks on three scales: grasp, performance time, and level of frustration.

    12 months

  • Detects expected change in a person's ability to to do various functions while performing a specific task and scoring their motions.

    This assessment will evaluate the ability of the myoelectric device use on functions that involve griping, holding, releasing, and coordinating between limbs using the Assessment of Capacity for Myoelectric Control (ACMC).

    12 months

  • This self-report or parent-report tool is used to assess musculoskeletal health of the myoelectric device user.

    This assessment contains six scales Upper Extremity Physical Function; Mobility/Transfers; Sports/Physical Function; Pain/Comfort; Happiness; and Global Function.

    12 months

  • A self-report and parent-report sectional approach to measuring health-related quality of life.

    This assessment uses four generic core scales including: physical health, emotional functioning, social functioning, and school functioning.

    12 months

Study Arms (1)

Prosthetic Device

EXPERIMENTAL

3D Printed Myoelectric Prosthetic Device

Device: 3D Printed Myoelectric Prosthetic Device

Interventions

3D Printed Myoelectric Prosthetic Device

Prosthetic Device

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children between the ages of 6 to 17 with congenital/infant upper limb deficiency identified by Limbitless Solutions will be referred to OHSU for evaluation and selection.
  • All approved and consented subjects will receive a Limbitless 3D printed myoelectric device as delivered by established protocol.
  • Preference will be given to children with long term previous experience with Limbitless Solutions' bionic systems.

You may not qualify if:

  • Non English-speaking children and families. Due to the entirely volunteer nature of this project, the investigators are unable to hire appropriate translation services or create translated forms and surveys in other languages currently.
  • Shoulder or wrist disarticulation will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The University of Central Florida

Orlando, Florida, 32816, United States

Location

Oregon Health & Science University

Portland, Oregon, 97239, United States

Location

Related Publications (2)

  • Canfield MA, Honein MA, Yuskiv N, Xing J, Mai CT, Collins JS, Devine O, Petrini J, Ramadhani TA, Hobbs CA, Kirby RS. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol. 2006 Nov;76(11):747-56. doi: 10.1002/bdra.20294.

    PMID: 17051527BACKGROUND
  • Blough DK, Hubbard S, McFarland LV, Smith DG, Gambel JM, Reiber GE. Prosthetic cost projections for servicemembers with major limb loss from Vietnam and OIF/OEF. J Rehabil Res Dev. 2010;47(4):387-402. doi: 10.1682/jrrd.2009.04.0037.

    PMID: 20803406BACKGROUND

Related Links

MeSH Terms

Conditions

Upper Extremity Deformities, Congenital

Condition Hierarchy (Ancestors)

Limb Deformities, CongenitalMusculoskeletal AbnormalitiesMusculoskeletal DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Albert Chi, MD

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 2, 2019

First Posted

August 16, 2019

Study Start

July 3, 2019

Primary Completion

September 30, 2021

Study Completion

December 31, 2021

Last Updated

March 10, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations